US Stock MarketDetailed Quotes
KNSA Kiniksa Pharmaceuticals International
- 25.200
- -1.090-4.15%
Close Jul 24 16:00 ET
1.79BMarket Cap-168000P/E (TTM)
26.559High24.845Low971.29KVolume26.000Open26.290Pre Close24.79MTurnover6.84%Turnover Ratio126.00P/E (Static)71.08MShares27.88052wk High4.12P/B357.68MFloat Cap14.12052wk Low--Dividend TTM14.19MShs Float32.880Historical High--Div YieldTTM6.52%Amplitude5.010Historical Low25.521Avg Price1Lot Size
About Kiniksa Pharmaceuticals International Company
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
Company Profile
SymbolKNSA
Company NameKiniksa Pharmaceuticals International
Listing DateMay 24, 2018
Issue Price18.00
Founded2024
CEOMr. Sanj K. Patel
MarketNASDAQ
Employees297
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address23 Old Bond Street,3rd Floor
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW1S 4PZ
Phone44-781-431-9100
Websitehttps://www.kiniksa.com
Company Executives
- Name
- Position
- Salary
- Sanj K. Patel
- Chief Executive Officer and Chairman of the Board
- 5.30M
- John F. Paolini, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 1.79M
- Michael R. Megna
- Chief Accounting Officer and Group Vice President, Finance
- --
- Ross Moat
- Senior Vice President and Chief Commercial Officer
- --
- Eben Tessari
- Senior Vice President and Chief Operating Officer
- 1.75M
- Mark Ragosa
- Senior Vice President and Chief Financial Officer
- --
- Kimberly J. Popovits
- Independent Director
- 362.66K
- Dr. Stephen R. Biggar,M.D.,PhD
- Independent Director
- 371.96K
- Dr. Felix J. Baker,PhD
- Lead Independent Director
- 411.06K
- Tracey L. McCain, Esq.
- Independent Director
- 365.36K
- Thomas R. Malley
- Independent Director
- 380.36K
- G. Bradley Cole
- Independent Director
- 365.36K
- Dr. Barry D. Quart,Pharm.D.
- Independent Director
- 372.55K
- Dr. Richard S. Levy,M.D.
- Independent Director
- 459.75K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
